Pre-Seed, Seed
$250K – $1.0M
32+ companies
1 partner
Investment Thesis
Invests at the intersection of pharma and SaaS, targeting startups driving pharmaceutical sales automation.
Meet the Team
Daniel Murphy
Partner
Industry Focus
Invests In
Does Not Invest In
Portfolio Companies (32)
Other
PharmaSync AI
Lumeris Group Holding Company
"Discovered via perplexity (medium confidence)"
Provides technology and services to help organizations transition to Accountable Delivery Systems (ADS).
Daymark Health
"Discovered via perplexity (medium confidence)"
Cancer care company partnering with health plans for in-home, virtual supportive, and wraparound care for cancer patients.
HealthEdge
"Discovered via perplexity (medium confidence)"
End-to-end digital technology solutions connecting health plans, providers, and patients for healthcare operations transformation.
Big Health
"Discovered via perplexity (medium confidence)"
Digital cognitive behavioral therapy (CBT) platform for insomnia, generalized anxiety disorder (GAD), and depression.
Belong Health
"Discovered via perplexity (medium confidence)"
Shared-risk platform helping local/regional health plans launch, grow, or remediate Medicare Advantage and Special Needs Plans.
Alacura
"Discovered via perplexity (medium confidence)"
Data analytics and network optimization for managing air medical transportation utilization.
Bluestone Physician Services
"Discovered via perplexity (medium confidence)"
Mobile geriatric primary care and care coordination provider.
CirrusMD
"Discovered via perplexity (medium confidence)"
Text-first digital front door solution for health plans and providers.
Drips
"Discovered via perplexity (medium confidence)"
AI-leveraged automated two-way conversational messaging platform to drive consumer action.
Browse More Investors
Frequently Asked Questions
See if Blue Pharma Ventures is a match for your startup
Upload your pitch deck to see how well you match with Blue Pharma Ventures and 200+ other VC firms.